Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tegoprazan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ami Lifesciences Submits US DMF for Tegoprazan
    Ami Lifesciences Submits US DMF for Tegoprazan

    08 Oct 2024

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    08 Oct 2024
    Share Share
    Malaysia Approves RaQualia's Tegoprazan For GERD Treatment
    Malaysia Approves RaQualia's Tegoprazan For GERD Treatment

    27 Sep 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24961/malaysia-gives-nod-to-raqualias-tegoprazan-for-gastroesophageal-reflux-disease-treatment.html

    BIOSPECTRUM ASIA
    27 Sep 2024
    Share Share
    Sebela Acquires Licensing Rights to Develop and Commercialize Tegoprazan
    Sebela Acquires Licensing Rights to Develop and Commercialize Tegoprazan

    20 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-acquires-exclusive-licensing-rights-to-develop-and-commercialize-tegoprazan-in-the-us-and-canada-301654039.html

    PRNEWSWIRE
    20 Oct 2022
    Share Share
    Dr. Reddy’s Laboratories to commercialise novel molecule Tegoprazan in India
    Dr. Reddy’s Laboratories to commercialise novel molecule Tegoprazan in India

    11 May 2022

    // FINANCIAL EXPRESS

    https://www.financialexpress.com/healthcare/pharma-healthcare/dr-reddys-laboratories-to-commercialise-novel-molecule-tegoprazan-in-india/2520304/

    FINANCIAL EXPRESS
    11 May 2022
    Share Share
    Combo drugs: latest trend in local pharmaceuticals
    Combo drugs: latest trend in local pharmaceuticals

    19 Aug 2019

    // Lee Hye-seon KOREAMED

    http://www.koreabiomed.com/news/articleView.html?idxno=6300

    Lee Hye-seon KOREAMED
    19 Aug 2019
    Share Share